Plain-English translation of NCT07109427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a simple tool in a doctor's computer system can help improve prostate cancer screening conversations. The study will place an automatic reminder in the electronic health record that prompts primary care doctors to discuss the benefits and risks of prostate-specific antigen (PSA) screening with eligible men. The goal is to make sure men get screening conversations that match current medical guidelines—catching cancer early when it matters, without screening unnecessarily.
Prostate cancer screening is complex: some men benefit from it, while others may be harmed by unnecessary testing or overdiagnosis. Doctors don't always have consistent conversations about screening with their patients. This study tests whether a simple electronic reminder can help doctors and patients make better, more informed decisions together about whether screening is right for each person.
You likely qualify if…
You likely don't qualify if…
Your participation is very simple—you don't need to do anything extra. When you visit your primary care doctor for routine care, your doctor may see an automatic reminder in their computer system prompting a discussion about prostate cancer screening. Your doctor will talk with you about the pros and cons of screening so you can decide together what's best for you. The study tracks whether these reminders help doctors have these important conversations more often.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
United States